Cephalon Inc. (CEPH)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
1090 HORSHAM ROAD, NORTH WALES, PA 19454
215 591 3000

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 6.131 Billion Shares Outstanding75.233 Million Avg 30-day Volume 4.445 Million
P/E Ratio12.7038 Dividend Yield0.0 EPS4.33
Price to Revenue2.3748 Debt to Equity0.305 EBITDA1.18 Billion
Price to Book Value2.1368 Operating Margin22.5225 Enterprise Value6.841 Billion
Current Ratio1.648 EPS Growth0 Quick Ratio1.167
1 Yr BETA 0.3035 52-week High/Low 0.0 / Profit Margin18.5717
Operating Cash Flow Growth-16.1131 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM420.791 Million
Altman Z-Score3.2621
View SEC Filings from CEPH instead.

View recent insider trading info

Cephalon Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CEPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CEPH

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILENSKY GAIL R

  • Director
 No longer subject to file 2011-10-14 0

EGAN WILLIAM P

  • Director
 No longer subject to file 2011-10-14 0

MOLEY KEVIN E

  • Director
 No longer subject to file 2011-10-14 0

KAILIAN VAUGHN M

  • Director
 No longer subject to file 2011-10-14 0

HOMCY CHARLES J

  • Director
 No longer subject to file 2011-10-14 0

VAUGHT JEFFRY L EXEC VP, CHIEF SCIENTIFIC OFF

  • Officer
 No longer subject to file 2011-10-14 0

SAVINI CARL A EXEC VP, CHIEF ADMIN OFF

  • Officer
 No longer subject to file 2011-10-14 0

BUCHI J KEVIN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 No longer subject to file 2011-10-14 0

GREENACRE MARTYN D

  • Director
 No longer subject to file 2011-10-14 0

WINGER DENNIS L

  • Director
 No longer subject to file 2011-10-14 0

RUSSELL LESLEY EXEC VP, CHIEF MEDICAL OFF

  • Officer
 No longer subject to file 2011-10-14 0

BALDASSANO VALLI F. EXEC VP, CHIEF COMPLIANCE OFF

  • Officer
 No longer subject to file 2011-10-14 0

PAPPERT GERALD J. EXEC VP & GENERAL COUNSEL

  • Officer
 0 2011-10-14 0

GROENHUYSEN WILCO EXEC VP & CFO

  • Officer
 0 2011-10-14 0

ARAGUES ALAIN EXEC VP, PRESIDENT EUROPE

  • Officer
 No longer subject to file 2011-10-14 0

GREBOW PETER E EXEC. V.P., CEPHALON VENTURES

  • Officer
 70,974 2010-12-20 0

BALDINO FRANK JR CHAIRMAN AND CEO

  • Officer
  • Director
 520,083 2010-12-13 0

SANDERS CHARLES A

  • Director
 0 2010-05-20 0

ROCHE ROBERT P JR EXEC. VP, WW PHARM OPS

  • Officer
 50,582 2009-12-21 0

OSBORN JOHN E EXEC VP, GENERAL COUNSEL & SEC

  • Officer
 47,680 2007-12-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments